

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.19184763 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.17870334 |
| 3 | tolerance induction (GO:0002507) | 4.61201727 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.32158641 |
| 5 | neutrophil activation involved in immune response (GO:0002283) | 4.27199227 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.08250267 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.08250267 |
| 8 | myeloid dendritic cell activation (GO:0001773) | 4.04183842 |
| 9 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.91966452 |
| 10 | myeloid dendritic cell differentiation (GO:0043011) | 3.91633702 |
| 11 | neutrophil activation (GO:0042119) | 3.84354150 |
| 12 | negative regulation of T cell mediated immunity (GO:0002710) | 3.74978870 |
| 13 | positive regulation of B cell differentiation (GO:0045579) | 3.74750132 |
| 14 | positive regulation of interferon-alpha production (GO:0032727) | 3.72848485 |
| 15 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.71850823 |
| 16 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.67446191 |
| 17 | negative regulation of interleukin-12 production (GO:0032695) | 3.67059216 |
| 18 | response to type I interferon (GO:0034340) | 3.65329539 |
| 19 | granulocyte activation (GO:0036230) | 3.65278223 |
| 20 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.64092639 |
| 21 | cellular response to type I interferon (GO:0071357) | 3.63596422 |
| 22 | type I interferon signaling pathway (GO:0060337) | 3.63596422 |
| 23 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.62016353 |
| 24 | positive regulation of antigen processing and presentation (GO:0002579) | 3.58080863 |
| 25 | regulation of interferon-alpha production (GO:0032647) | 3.56132906 |
| 26 | defense response to protozoan (GO:0042832) | 3.55755127 |
| 27 | histone H3-K36 demethylation (GO:0070544) | 3.52490071 |
| 28 | regulation of chronic inflammatory response (GO:0002676) | 3.50915454 |
| 29 | neutrophil mediated immunity (GO:0002446) | 3.49720917 |
| 30 | response to muramyl dipeptide (GO:0032495) | 3.48185138 |
| 31 | regulation of gamma-delta T cell activation (GO:0046643) | 3.47914089 |
| 32 | mast cell activation (GO:0045576) | 3.47673483 |
| 33 | interferon-gamma secretion (GO:0072643) | 3.46110848 |
| 34 | T-helper 1 type immune response (GO:0042088) | 3.45048747 |
| 35 | positive regulation of interleukin-2 production (GO:0032743) | 3.44916072 |
| 36 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.44227438 |
| 37 | regulation of B cell differentiation (GO:0045577) | 3.43981380 |
| 38 | positive regulation of interferon-beta production (GO:0032728) | 3.42512730 |
| 39 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.40708979 |
| 40 | NIK/NF-kappaB signaling (GO:0038061) | 3.39617082 |
| 41 | regulation of activation of Janus kinase activity (GO:0010533) | 3.38758681 |
| 42 | dendritic cell chemotaxis (GO:0002407) | 3.38544006 |
| 43 | cellular response to exogenous dsRNA (GO:0071360) | 3.38133141 |
| 44 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.37794028 |
| 45 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.37479130 |
| 46 | negative regulation of cell killing (GO:0031342) | 3.37479130 |
| 47 | respiratory burst (GO:0045730) | 3.36632623 |
| 48 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.36162060 |
| 49 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.34378755 |
| 50 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.34378755 |
| 51 | modulation by symbiont of host immune response (GO:0052553) | 3.34378755 |
| 52 | positive regulation by symbiont of host defense response (GO:0052509) | 3.34378755 |
| 53 | modulation by symbiont of host defense response (GO:0052031) | 3.34378755 |
| 54 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.34378755 |
| 55 | T cell migration (GO:0072678) | 3.34290779 |
| 56 | cellular extravasation (GO:0045123) | 3.34018104 |
| 57 | interferon-gamma production (GO:0032609) | 3.32927439 |
| 58 | negative T cell selection (GO:0043383) | 3.32415514 |
| 59 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.31022399 |
| 60 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.31022399 |
| 61 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.31022399 |
| 62 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.30748954 |
| 63 | negative thymic T cell selection (GO:0045060) | 3.29935211 |
| 64 | activated T cell proliferation (GO:0050798) | 3.29461774 |
| 65 | response to protozoan (GO:0001562) | 3.29345142 |
| 66 | positive regulation of interleukin-12 production (GO:0032735) | 3.28217327 |
| 67 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.27670644 |
| 68 | immunoglobulin mediated immune response (GO:0016064) | 3.24417800 |
| 69 | response to peptidoglycan (GO:0032494) | 3.22556032 |
| 70 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.19258387 |
| 71 | positive regulation of tolerance induction (GO:0002645) | 3.17911641 |
| 72 | B cell receptor signaling pathway (GO:0050853) | 3.17563181 |
| 73 | positive regulation of isotype switching (GO:0045830) | 3.17291281 |
| 74 | cellular response to interferon-beta (GO:0035458) | 3.17242314 |
| 75 | positive regulation of granulocyte differentiation (GO:0030854) | 3.16904014 |
| 76 | positive regulation of defense response to virus by host (GO:0002230) | 3.16070746 |
| 77 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.15124793 |
| 78 | myeloid leukocyte mediated immunity (GO:0002444) | 3.15096529 |
| 79 | myeloid cell activation involved in immune response (GO:0002275) | 3.14529663 |
| 80 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.14477336 |
| 81 | leukocyte aggregation (GO:0070486) | 3.13473782 |
| 82 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.12212485 |
| 83 | positive T cell selection (GO:0043368) | 3.09527723 |
| 84 | mature B cell differentiation (GO:0002335) | 3.07947883 |
| 85 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.06079412 |
| 86 | negative regulation of interleukin-17 production (GO:0032700) | 3.05878592 |
| 87 | T cell selection (GO:0045058) | 3.04835669 |
| 88 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.03387512 |
| 89 | positive regulation of DNA recombination (GO:0045911) | 3.02120522 |
| 90 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.01250187 |
| 91 | germinal center formation (GO:0002467) | 3.01009134 |
| 92 | positive regulation of humoral immune response (GO:0002922) | 2.99801962 |
| 93 | dendritic cell differentiation (GO:0097028) | 2.98503911 |
| 94 | positive regulation of mRNA catabolic process (GO:0061014) | 2.96127681 |
| 95 | regulation of T cell tolerance induction (GO:0002664) | 2.95937065 |
| 96 | regulation of tolerance induction (GO:0002643) | 2.95922659 |
| 97 | detection of other organism (GO:0098543) | 2.95818829 |
| 98 | regulation of antigen processing and presentation (GO:0002577) | 2.95457256 |
| 99 | myeloid leukocyte activation (GO:0002274) | 2.95432019 |
| 100 | regulation of RIG-I signaling pathway (GO:0039535) | 2.94888381 |
| 101 | response to interleukin-15 (GO:0070672) | 2.94330937 |
| 102 | positive regulation of B cell mediated immunity (GO:0002714) | 2.93733375 |
| 103 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.93733375 |
| 104 | regulation of hypersensitivity (GO:0002883) | 2.92898672 |
| 105 | dendritic cell migration (GO:0036336) | 2.89860384 |
| 106 | cellular response to interleukin-15 (GO:0071350) | 2.88977835 |
| 107 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.88229818 |
| 108 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.86432396 |
| 109 | positive regulation of interferon-gamma production (GO:0032729) | 2.86146804 |
| 110 | negative regulation of viral genome replication (GO:0045071) | 2.86031781 |
| 111 | natural killer cell activation (GO:0030101) | 2.85961274 |
| 112 | macrophage activation involved in immune response (GO:0002281) | 2.85576998 |
| 113 | regulation of interferon-beta production (GO:0032648) | 2.85315708 |
| 114 | B cell mediated immunity (GO:0019724) | 2.84986206 |
| 115 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.84029079 |
| 116 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.84029079 |
| 117 | T cell homeostasis (GO:0043029) | 2.83836373 |
| 118 | cellular response to zinc ion (GO:0071294) | 2.83634622 |
| 119 | response to interferon-beta (GO:0035456) | 2.83447589 |
| 120 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.83354574 |
| 121 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.82737425 |
| 122 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.81793918 |
| 123 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.81747275 |
| 124 | regulation of germinal center formation (GO:0002634) | 2.81441302 |
| 125 | regulation of interleukin-12 production (GO:0032655) | 2.80542898 |
| 126 | regulation of T-helper cell differentiation (GO:0045622) | 2.80491848 |
| 127 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.80365278 |
| 128 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.79587275 |
| 129 | leukocyte degranulation (GO:0043299) | 2.78880458 |
| 130 | detection of bacterium (GO:0016045) | 2.78441333 |
| 131 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.77635587 |
| 132 | microglial cell activation (GO:0001774) | 2.76769176 |
| 133 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.76691101 |
| 134 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.76676622 |
| 135 | B cell homeostasis (GO:0001782) | 2.76159895 |
| 136 | positive regulation of B cell activation (GO:0050871) | 2.75939955 |
| 137 | positive regulation of interleukin-10 production (GO:0032733) | 2.75815741 |
| 138 | regulation of regulatory T cell differentiation (GO:0045589) | 2.75448333 |
| 139 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.70907394 |
| 140 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.70907394 |
| 141 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.66449385 |
| 142 | regulation of isotype switching (GO:0045191) | 2.66201006 |
| 143 | cellular response to ethanol (GO:0071361) | 2.66090142 |
| 144 | negative regulation of type 2 immune response (GO:0002829) | 2.64407991 |
| 145 | regulation of mRNA catabolic process (GO:0061013) | 2.58147292 |
| 146 | regulation of chemokine biosynthetic process (GO:0045073) | 2.55703277 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.14595299 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.52489889 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.25615227 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.90603838 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.81938729 |
| 6 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.62824009 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.13180969 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.84444390 |
| 9 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.63452165 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.44792417 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.42109221 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.37452109 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.98107799 |
| 14 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.90701780 |
| 15 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.78418468 |
| 16 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.78418468 |
| 17 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.78418468 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.77465481 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.72302600 |
| 20 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.67948784 |
| 21 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.42337956 |
| 22 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.31324880 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.28661163 |
| 24 | * MYB_26560356_Chip-Seq_TH2_Human | 2.23811575 |
| 25 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.20444961 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.19401171 |
| 27 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94608442 |
| 28 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.91999108 |
| 29 | MYB_26560356_Chip-Seq_TH1_Human | 1.90495665 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.88880653 |
| 31 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78267813 |
| 32 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.76879682 |
| 33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.74213043 |
| 34 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.73272854 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.73061724 |
| 36 | * MAF_26560356_Chip-Seq_TH1_Human | 1.72486049 |
| 37 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71501325 |
| 38 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.70429384 |
| 39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.69500066 |
| 40 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.68380991 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.68310556 |
| 42 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.63686114 |
| 43 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.63321207 |
| 44 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.62742769 |
| 45 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.59497249 |
| 46 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.58972269 |
| 47 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.57566683 |
| 48 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.56816489 |
| 49 | GATA1_22025678_ChIP-Seq_K562_Human | 1.56078136 |
| 50 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.53611173 |
| 51 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.51520054 |
| 52 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.41601125 |
| 53 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.39615855 |
| 54 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.36330127 |
| 55 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34999028 |
| 56 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.34383420 |
| 57 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.33212896 |
| 58 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30715528 |
| 59 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.29318446 |
| 60 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.27469489 |
| 61 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.26966944 |
| 62 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.24648643 |
| 63 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.23529500 |
| 64 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.22593994 |
| 65 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.21938845 |
| 66 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21292126 |
| 67 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.20421019 |
| 68 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.19712928 |
| 69 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.16741560 |
| 70 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.15856093 |
| 71 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.15076786 |
| 72 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.14770186 |
| 73 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14352964 |
| 74 | MYC_22102868_ChIP-Seq_BL_Human | 1.10174393 |
| 75 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08024405 |
| 76 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06405126 |
| 77 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05350548 |
| 78 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.04156084 |
| 79 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.03768063 |
| 80 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.03004694 |
| 81 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02980220 |
| 82 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.00158642 |
| 83 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.99602714 |
| 84 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98345933 |
| 85 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98032905 |
| 86 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98007443 |
| 87 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.98002643 |
| 88 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.97666666 |
| 89 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.96891243 |
| 90 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.94551148 |
| 91 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.93749833 |
| 92 | MAF_26560356_Chip-Seq_TH2_Human | 0.92558167 |
| 93 | GATA3_26560356_Chip-Seq_TH1_Human | 0.92082185 |
| 94 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.91494950 |
| 95 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.90820990 |
| 96 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.90138576 |
| 97 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89106604 |
| 98 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.89106604 |
| 99 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88686137 |
| 100 | GATA2_19941826_ChIP-Seq_K562_Human | 0.88682648 |
| 101 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88503989 |
| 102 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87894616 |
| 103 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87488573 |
| 104 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.85288047 |
| 105 | EWS_26573619_Chip-Seq_HEK293_Human | 0.84002591 |
| 106 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.78115266 |
| 107 | GATA1_19941826_ChIP-Seq_K562_Human | 0.76884474 |
| 108 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.76287920 |
| 109 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.76079555 |
| 110 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.75878608 |
| 111 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.75092485 |
| 112 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.73492997 |
| 113 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.71372990 |
| 114 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.70756931 |
| 115 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.70613127 |
| 116 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.69536956 |
| 117 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.69305042 |
| 118 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.68968425 |
| 119 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.68422078 |
| 120 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.66990819 |
| 121 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.66326318 |
| 122 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.66296439 |
| 123 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.66123681 |
| 124 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.65638120 |
| 125 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.65496157 |
| 126 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.65412533 |
| 127 | RXR_22108803_ChIP-Seq_LS180_Human | 0.64540025 |
| 128 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.64405695 |
| 129 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.63339914 |
| 130 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.62928195 |
| 131 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.62008309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.83633548 |
| 2 | MP0005671_abnormal_response_to | 3.78180576 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 3.53381650 |
| 4 | MP0009785_altered_susceptibility_to | 3.43758743 |
| 5 | MP0000685_abnormal_immune_system | 3.29476658 |
| 6 | MP0001790_abnormal_immune_system | 3.24059993 |
| 7 | MP0005387_immune_system_phenotype | 3.24059993 |
| 8 | MP0003436_decreased_susceptibility_to | 3.15823198 |
| 9 | MP0005000_abnormal_immune_tolerance | 3.01875035 |
| 10 | MP0001800_abnormal_humoral_immune | 2.89478381 |
| 11 | MP0005025_abnormal_response_to | 2.83474942 |
| 12 | MP0002419_abnormal_innate_immunity | 2.82153963 |
| 13 | MP0003724_increased_susceptibility_to | 2.78685214 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.75200437 |
| 15 | MP0002723_abnormal_immune_serum | 2.71014303 |
| 16 | MP0001819_abnormal_immune_cell | 2.55937834 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.54709934 |
| 18 | MP0004510_myositis | 2.46667404 |
| 19 | MP0002166_altered_tumor_susceptibility | 2.30591389 |
| 20 | MP0006082_CNS_inflammation | 2.27945854 |
| 21 | MP0002398_abnormal_bone_marrow | 2.25961341 |
| 22 | MP0002006_tumorigenesis | 2.22615296 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.20090599 |
| 24 | MP0002396_abnormal_hematopoietic_system | 2.16989604 |
| 25 | MP0000716_abnormal_immune_system | 2.08669641 |
| 26 | MP0002405_respiratory_system_inflammati | 2.06375364 |
| 27 | MP0003763_abnormal_thymus_physiology | 2.05642872 |
| 28 | MP0005397_hematopoietic_system_phenotyp | 2.03962607 |
| 29 | MP0001545_abnormal_hematopoietic_system | 2.03962607 |
| 30 | MP0003303_peritoneal_inflammation | 2.00201399 |
| 31 | MP0000569_abnormal_digit_pigmentation | 1.94221715 |
| 32 | MP0001853_heart_inflammation | 1.89815302 |
| 33 | MP0008877_abnormal_DNA_methylation | 1.88187555 |
| 34 | MP0004808_abnormal_hematopoietic_stem | 1.76226002 |
| 35 | MP0005174_abnormal_tail_pigmentation | 1.75534129 |
| 36 | MP0000689_abnormal_spleen_morphology | 1.72826124 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.72582186 |
| 38 | MP0005451_abnormal_body_composition | 1.71201337 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.71061285 |
| 40 | MP0002429_abnormal_blood_cell | 1.69362979 |
| 41 | MP0009764_decreased_sensitivity_to | 1.64445178 |
| 42 | MP0002722_abnormal_immune_system | 1.64089573 |
| 43 | MP0002138_abnormal_hepatobiliary_system | 1.62091180 |
| 44 | MP0005310_abnormal_salivary_gland | 1.60933950 |
| 45 | MP0003172_abnormal_lysosome_physiology | 1.48056108 |
| 46 | MP0008469_abnormal_protein_level | 1.44899272 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.42865197 |
| 48 | MP0000703_abnormal_thymus_morphology | 1.37877075 |
| 49 | MP0004947_skin_inflammation | 1.37329951 |
| 50 | MP0009278_abnormal_bone_marrow | 1.28410056 |
| 51 | MP0000015_abnormal_ear_pigmentation | 1.27252765 |
| 52 | MP0009333_abnormal_splenocyte_physiolog | 1.26870031 |
| 53 | MP0003183_abnormal_peptide_metabolism | 1.26239629 |
| 54 | MP0002139_abnormal_hepatobiliary_system | 1.25612980 |
| 55 | MP0003866_abnormal_defecation | 1.20565362 |
| 56 | MP0002132_abnormal_respiratory_system | 1.18971160 |
| 57 | MP0001873_stomach_inflammation | 1.18067413 |
| 58 | MP0003191_abnormal_cellular_cholesterol | 1.17230407 |
| 59 | MP0003448_altered_tumor_morphology | 1.16576593 |
| 60 | MP0000858_altered_metastatic_potential | 1.15625258 |
| 61 | MP0008004_abnormal_stomach_pH | 1.08590634 |
| 62 | MP0003787_abnormal_imprinting | 1.07476123 |
| 63 | MP0003075_altered_response_to | 1.01182317 |
| 64 | MP0000465_gastrointestinal_hemorrhage | 1.00612996 |
| 65 | MP0005075_abnormal_melanosome_morpholog | 0.98351073 |
| 66 | MP0008057_abnormal_DNA_replication | 0.97835779 |
| 67 | MP0002998_abnormal_bone_remodeling | 0.96094831 |
| 68 | MP0004147_increased_porphyrin_level | 0.95248092 |
| 69 | MP0002277_abnormal_respiratory_mucosa | 0.94817190 |
| 70 | MP0003943_abnormal_hepatobiliary_system | 0.93725818 |
| 71 | MP0002009_preneoplasia | 0.92232564 |
| 72 | MP0005058_abnormal_lysosome_morphology | 0.91001805 |
| 73 | MP0003195_calcinosis | 0.90868211 |
| 74 | MP0002163_abnormal_gland_morphology | 0.90691081 |
| 75 | MP0000490_abnormal_crypts_of | 0.89422939 |
| 76 | MP0001986_abnormal_taste_sensitivity | 0.89215754 |
| 77 | MP0002095_abnormal_skin_pigmentation | 0.88552434 |
| 78 | MP0003828_pulmonary_edema | 0.88472397 |
| 79 | MP0005647_abnormal_sex_gland | 0.87131980 |
| 80 | MP0003300_gastrointestinal_ulcer | 0.85663795 |
| 81 | MP0002876_abnormal_thyroid_physiology | 0.83693541 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 0.81492929 |
| 83 | MP0004782_abnormal_surfactant_physiolog | 0.79856339 |
| 84 | MP0002933_joint_inflammation | 0.78457089 |
| 85 | MP0009763_increased_sensitivity_to | 0.76331224 |
| 86 | MP0004130_abnormal_muscle_cell | 0.74867603 |
| 87 | MP0000343_altered_response_to | 0.72589493 |
| 88 | MP0009697_abnormal_copulation | 0.71332623 |
| 89 | MP0008058_abnormal_DNA_repair | 0.69571685 |
| 90 | MP0003252_abnormal_bile_duct | 0.67629336 |
| 91 | MP0009115_abnormal_fat_cell | 0.66189481 |
| 92 | MP0001851_eye_inflammation | 0.65755684 |
| 93 | MP0001764_abnormal_homeostasis | 0.63811689 |
| 94 | MP0003693_abnormal_embryo_hatching | 0.63217680 |
| 95 | MP0008961_abnormal_basal_metabolism | 0.63144662 |
| 96 | MP0006054_spinal_hemorrhage | 0.61865048 |
| 97 | MP0005379_endocrine/exocrine_gland_phen | 0.61286823 |
| 98 | MP0001348_abnormal_lacrimal_gland | 0.60920354 |
| 99 | MP0003045_fibrosis | 0.60793124 |
| 100 | MP0000249_abnormal_blood_vessel | 0.60757038 |
| 101 | MP0004142_abnormal_muscle_tone | 0.60691331 |
| 102 | MP0002693_abnormal_pancreas_physiology | 0.60348060 |
| 103 | MP0001919_abnormal_reproductive_system | 0.59193933 |
| 104 | MP0008874_decreased_physiological_sensi | 0.58569783 |
| 105 | MP0003221_abnormal_cardiomyocyte_apopto | 0.58532513 |
| 106 | MP0005166_decreased_susceptibility_to | 0.58497959 |
| 107 | MP0004883_abnormal_blood_vessel | 0.57844807 |
| 108 | MP0002332_abnormal_exercise_endurance | 0.57606830 |
| 109 | MP0010094_abnormal_chromosome_stability | 0.57362862 |
| 110 | MP0005409_darkened_coat_color | 0.57222047 |
| 111 | MP0005266_abnormal_metabolism | 0.56714396 |
| 112 | MP0008007_abnormal_cellular_replicative | 0.56544767 |
| 113 | MP0002019_abnormal_tumor_incidence | 0.56302674 |
| 114 | MP0002735_abnormal_chemical_nociception | 0.56133304 |
| 115 | MP0000604_amyloidosis | 0.55151718 |
| 116 | MP0000371_diluted_coat_color | 0.54704385 |
| 117 | MP0001501_abnormal_sleep_pattern | 0.53728057 |
| 118 | MP0008260_abnormal_autophagy | 0.52482714 |
| 119 | MP0002653_abnormal_ependyma_morphology | 0.51771843 |
| 120 | MP0003690_abnormal_glial_cell | 0.51112609 |
| 121 | MP0002733_abnormal_thermal_nociception | 0.51041267 |
| 122 | MP0002254_reproductive_system_inflammat | 0.50888772 |
| 123 | MP0006292_abnormal_olfactory_placode | 0.50423969 |
| 124 | MP0005390_skeleton_phenotype | 0.49914023 |
| 125 | MP0003718_maternal_effect | 0.49391689 |
| 126 | MP0005076_abnormal_cell_differentiation | 0.47824275 |
| 127 | MP0009765_abnormal_xenobiotic_induced | 0.46944070 |
| 128 | MP0001663_abnormal_digestive_system | 0.46173690 |
| 129 | MP0002928_abnormal_bile_duct | 0.44654023 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.97228398 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.70783043 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.16784488 |
| 4 | Myositis (HP:0100614) | 4.53521186 |
| 5 | Retrobulbar optic neuritis (HP:0100654) | 4.36634756 |
| 6 | Optic neuritis (HP:0100653) | 4.36634756 |
| 7 | Mediastinal lymphadenopathy (HP:0100721) | 4.30864974 |
| 8 | Recurrent fungal infections (HP:0002841) | 4.24414741 |
| 9 | Recurrent viral infections (HP:0004429) | 4.15590690 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.13173865 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.08392605 |
| 12 | Orchitis (HP:0100796) | 3.97009513 |
| 13 | Chronic otitis media (HP:0000389) | 3.90638520 |
| 14 | Recurrent skin infections (HP:0001581) | 3.69334184 |
| 15 | Autoimmune thrombocytopenia (HP:0001973) | 3.62138610 |
| 16 | Meningitis (HP:0001287) | 3.48153440 |
| 17 | Autoimmune hemolytic anemia (HP:0001890) | 3.46875697 |
| 18 | Periodontitis (HP:0000704) | 3.43876250 |
| 19 | Vasculitis (HP:0002633) | 3.42975948 |
| 20 | Abnormality of macrophages (HP:0004311) | 3.36241355 |
| 21 | Genetic anticipation (HP:0003743) | 3.34505295 |
| 22 | Panhypogammaglobulinemia (HP:0003139) | 3.33098749 |
| 23 | Gingivitis (HP:0000230) | 3.30546875 |
| 24 | Recurrent cutaneous fungal infections (HP:0011370) | 3.22547015 |
| 25 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.22547015 |
| 26 | Increased IgM level (HP:0003496) | 3.22398172 |
| 27 | Petechiae (HP:0000967) | 3.17716269 |
| 28 | Obstructive lung disease (HP:0006536) | 3.14029886 |
| 29 | Chronic obstructive pulmonary disease (HP:0006510) | 3.14029886 |
| 30 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.13139487 |
| 31 | Stomatitis (HP:0010280) | 3.07214242 |
| 32 | Pulmonary infiltrates (HP:0002113) | 3.04961143 |
| 33 | Agammaglobulinemia (HP:0004432) | 3.02841208 |
| 34 | Abnormality of the fingertips (HP:0001211) | 3.02183941 |
| 35 | Prolonged bleeding time (HP:0003010) | 2.99645804 |
| 36 | Acute lymphatic leukemia (HP:0006721) | 2.96939355 |
| 37 | IgM deficiency (HP:0002850) | 2.96592647 |
| 38 | Cellulitis (HP:0100658) | 2.93660061 |
| 39 | Recurrent bronchitis (HP:0002837) | 2.87314363 |
| 40 | Abnormality of T cell number (HP:0011839) | 2.81760133 |
| 41 | Thyroiditis (HP:0100646) | 2.81459032 |
| 42 | Stomach cancer (HP:0012126) | 2.78600125 |
| 43 | Abolished electroretinogram (ERG) (HP:0000550) | 2.76581241 |
| 44 | Keratoconjunctivitis sicca (HP:0001097) | 2.75370652 |
| 45 | Eosinophilia (HP:0001880) | 2.74449896 |
| 46 | Thrombocytosis (HP:0001894) | 2.72308875 |
| 47 | Arterial thrombosis (HP:0004420) | 2.70995474 |
| 48 | Encephalitis (HP:0002383) | 2.70636068 |
| 49 | Nasal polyposis (HP:0100582) | 2.65068451 |
| 50 | Hemoptysis (HP:0002105) | 2.65047736 |
| 51 | Gingival bleeding (HP:0000225) | 2.64195701 |
| 52 | T lymphocytopenia (HP:0005403) | 2.62817777 |
| 53 | Leukocytosis (HP:0001974) | 2.62107147 |
| 54 | IgG deficiency (HP:0004315) | 2.61484404 |
| 55 | Abnormality of the prostate (HP:0008775) | 2.54208885 |
| 56 | Epistaxis (HP:0000421) | 2.52866704 |
| 57 | Keratoconjunctivitis (HP:0001096) | 2.51893093 |
| 58 | Pustule (HP:0200039) | 2.51003276 |
| 59 | Hypoplasia of the thymus (HP:0000778) | 2.50035501 |
| 60 | B lymphocytopenia (HP:0010976) | 2.49014010 |
| 61 | Abnormality of B cell number (HP:0010975) | 2.49014010 |
| 62 | Abnormality of T cells (HP:0002843) | 2.47690706 |
| 63 | Hypergammaglobulinemia (HP:0010702) | 2.47253069 |
| 64 | Abnormality of eosinophils (HP:0001879) | 2.47142920 |
| 65 | Osteomyelitis (HP:0002754) | 2.47004897 |
| 66 | Recurrent pneumonia (HP:0006532) | 2.45088682 |
| 67 | Chronic sinusitis (HP:0011109) | 2.44631793 |
| 68 | Systemic lupus erythematosus (HP:0002725) | 2.44098801 |
| 69 | Alveolar cell carcinoma (HP:0006519) | 2.42802608 |
| 70 | Granulocytopenia (HP:0001913) | 2.42632429 |
| 71 | Slow saccadic eye movements (HP:0000514) | 2.40099295 |
| 72 | Inflammation of the large intestine (HP:0002037) | 2.37752516 |
| 73 | Basal ganglia calcification (HP:0002135) | 2.37228511 |
| 74 | Disinhibition (HP:0000734) | 2.36475239 |
| 75 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.36258075 |
| 76 | Acute myeloid leukemia (HP:0004808) | 2.36136304 |
| 77 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.32214060 |
| 78 | Interstitial pulmonary disease (HP:0006530) | 2.31634895 |
| 79 | Abnormality of the nasal mucosa (HP:0000433) | 2.29360243 |
| 80 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.28911349 |
| 81 | Lymphopenia (HP:0001888) | 2.28008867 |
| 82 | Abnormal hair whorl (HP:0010721) | 2.26228791 |
| 83 | Amaurosis fugax (HP:0100576) | 2.25059310 |
| 84 | Chronic diarrhea (HP:0002028) | 2.24301298 |
| 85 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.23850893 |
| 86 | Vacuolated lymphocytes (HP:0001922) | 2.21839054 |
| 87 | Severe combined immunodeficiency (HP:0004430) | 2.19508063 |
| 88 | Gastrointestinal inflammation (HP:0004386) | 2.18936579 |
| 89 | Hematochezia (HP:0002573) | 2.17371362 |
| 90 | Prostate neoplasm (HP:0100787) | 2.16880690 |
| 91 | Gastrointestinal infarctions (HP:0005244) | 2.16518703 |
| 92 | Cheilitis (HP:0100825) | 2.15677109 |
| 93 | Urticaria (HP:0001025) | 2.14656430 |
| 94 | Chest pain (HP:0100749) | 2.14571345 |
| 95 | Abnormality of the columella (HP:0009929) | 2.12972312 |
| 96 | Abnormality of T cell physiology (HP:0011840) | 2.12956607 |
| 97 | IgA deficiency (HP:0002720) | 2.12347118 |
| 98 | Joint swelling (HP:0001386) | 2.12288214 |
| 99 | Increased cerebral lipofuscin (HP:0011813) | 2.11116788 |
| 100 | Recurrent lower respiratory tract infections (HP:0002783) | 2.10337561 |
| 101 | Gastrointestinal stroma tumor (HP:0100723) | 2.10253568 |
| 102 | Gangrene (HP:0100758) | 2.08362132 |
| 103 | Colitis (HP:0002583) | 2.07753342 |
| 104 | Gonadotropin excess (HP:0000837) | 2.07511350 |
| 105 | Recurrent sinusitis (HP:0011108) | 2.05895281 |
| 106 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.02925868 |
| 107 | Cellular immunodeficiency (HP:0005374) | 2.01586515 |
| 108 | Spontaneous hematomas (HP:0007420) | 2.01109523 |
| 109 | Abnormal platelet function (HP:0011869) | 1.99967597 |
| 110 | Impaired platelet aggregation (HP:0003540) | 1.99967597 |
| 111 | Clumsiness (HP:0002312) | 1.98687352 |
| 112 | Viral hepatitis (HP:0006562) | 1.94864022 |
| 113 | Keratitis (HP:0000491) | 1.90898912 |
| 114 | Progressive cerebellar ataxia (HP:0002073) | 1.90152527 |
| 115 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.89519633 |
| 116 | Neutropenia (HP:0001875) | 1.88425575 |
| 117 | Increased IgE level (HP:0003212) | 1.87184148 |
| 118 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.86585746 |
| 119 | Purpura (HP:0000979) | 1.86076249 |
| 120 | Combined immunodeficiency (HP:0005387) | 1.84290015 |
| 121 | Agnosia (HP:0010524) | 1.82569004 |
| 122 | Inappropriate behavior (HP:0000719) | 1.82458910 |
| 123 | Sepsis (HP:0100806) | 1.81550499 |
| 124 | Lymphoma (HP:0002665) | 1.80803863 |
| 125 | Polyneuropathy (HP:0001271) | 1.80135094 |
| 126 | Bronchitis (HP:0012387) | 1.75417164 |
| 127 | Colon cancer (HP:0003003) | 1.73049341 |
| 128 | Pulmonary embolism (HP:0002204) | 1.72899487 |
| 129 | Basal cell carcinoma (HP:0002671) | 1.72701871 |
| 130 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.72303842 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 3.63689660 |
| 2 | MAP3K14 | 3.54091071 |
| 3 | MAP4K1 | 3.42077238 |
| 4 | RIPK4 | 3.10178025 |
| 5 | JAK3 | 3.05541453 |
| 6 | SIK3 | 3.05225989 |
| 7 | IRAK4 | 2.96305728 |
| 8 | BLK | 2.75504070 |
| 9 | TYK2 | 2.70942584 |
| 10 | TBK1 | 2.62610249 |
| 11 | IKBKE | 2.57447762 |
| 12 | FES | 2.35619717 |
| 13 | KIT | 2.30128998 |
| 14 | IKBKB | 2.19541553 |
| 15 | TEC | 2.06255511 |
| 16 | SYK | 2.00852301 |
| 17 | ZAP70 | 1.90490941 |
| 18 | BTK | 1.87940887 |
| 19 | DYRK3 | 1.82692206 |
| 20 | JAK1 | 1.76953152 |
| 21 | TAOK3 | 1.76809029 |
| 22 | MAP3K12 | 1.73458725 |
| 23 | NTRK3 | 1.63269026 |
| 24 | SIK2 | 1.62248738 |
| 25 | CHUK | 1.55753931 |
| 26 | IRAK3 | 1.54899587 |
| 27 | CAMKK2 | 1.53053063 |
| 28 | TRIM28 | 1.52537632 |
| 29 | CDK19 | 1.51680025 |
| 30 | HCK | 1.50237678 |
| 31 | TNIK | 1.49445752 |
| 32 | BMPR2 | 1.43485074 |
| 33 | MAP3K13 | 1.37032550 |
| 34 | FGR | 1.33937252 |
| 35 | MAP4K2 | 1.32280728 |
| 36 | ITK | 1.26278797 |
| 37 | TGFBR2 | 1.24463441 |
| 38 | LCK | 1.23975069 |
| 39 | YES1 | 1.22612584 |
| 40 | PIM2 | 1.20385972 |
| 41 | RPS6KA4 | 1.16779474 |
| 42 | CSF1R | 1.13360067 |
| 43 | PIM1 | 1.12566829 |
| 44 | LYN | 1.12490087 |
| 45 | FGFR3 | 1.12161960 |
| 46 | CDK12 | 1.08102553 |
| 47 | DYRK1B | 1.07805469 |
| 48 | MARK2 | 1.05919804 |
| 49 | MAP3K6 | 1.04295843 |
| 50 | BRD4 | 1.02590975 |
| 51 | PRPF4B | 1.01284240 |
| 52 | MAP2K7 | 1.00221667 |
| 53 | FGFR4 | 0.99255692 |
| 54 | CSK | 0.98092319 |
| 55 | TAOK1 | 0.96670344 |
| 56 | HIPK2 | 0.95817120 |
| 57 | JAK2 | 0.94914566 |
| 58 | MAP3K4 | 0.93563824 |
| 59 | GRK7 | 0.90998664 |
| 60 | MAP3K11 | 0.87761056 |
| 61 | STK10 | 0.87306723 |
| 62 | NEK9 | 0.86114850 |
| 63 | MAP2K3 | 0.82394674 |
| 64 | TESK2 | 0.81955515 |
| 65 | CDK4 | 0.81124142 |
| 66 | DAPK1 | 0.79866503 |
| 67 | STK4 | 0.79126630 |
| 68 | EIF2AK2 | 0.78263937 |
| 69 | TNK2 | 0.72836058 |
| 70 | EPHA4 | 0.72524002 |
| 71 | PRKCQ | 0.70160682 |
| 72 | FLT3 | 0.67187235 |
| 73 | IRAK1 | 0.66614070 |
| 74 | EPHA3 | 0.66436720 |
| 75 | CAMK4 | 0.64299719 |
| 76 | TRPM7 | 0.62964136 |
| 77 | MKNK1 | 0.62859664 |
| 78 | ERN1 | 0.62838782 |
| 79 | GRK5 | 0.62625990 |
| 80 | ZAK | 0.62397571 |
| 81 | MST4 | 0.61040791 |
| 82 | CDC7 | 0.60739300 |
| 83 | GRK6 | 0.60073907 |
| 84 | ATR | 0.59984805 |
| 85 | WNK3 | 0.59903199 |
| 86 | NLK | 0.59350769 |
| 87 | CDK3 | 0.59102088 |
| 88 | MATK | 0.59097888 |
| 89 | MKNK2 | 0.58961352 |
| 90 | DYRK1A | 0.55933699 |
| 91 | MAP3K5 | 0.55279886 |
| 92 | DYRK2 | 0.53565874 |
| 93 | ADRBK2 | 0.53506436 |
| 94 | CLK1 | 0.52175832 |
| 95 | FRK | 0.50585651 |
| 96 | TYRO3 | 0.49563385 |
| 97 | WNK1 | 0.48841983 |
| 98 | ERBB3 | 0.48801706 |
| 99 | PRKCD | 0.48442898 |
| 100 | CAMK1G | 0.48271842 |
| 101 | VRK1 | 0.47917230 |
| 102 | SGK2 | 0.47783219 |
| 103 | MARK3 | 0.47766351 |
| 104 | SGK3 | 0.47025184 |
| 105 | ALK | 0.46851599 |
| 106 | SGK494 | 0.46678076 |
| 107 | SGK223 | 0.46678076 |
| 108 | MAP3K7 | 0.46345497 |
| 109 | PDGFRB | 0.46330359 |
| 110 | MAPK7 | 0.46223451 |
| 111 | STK24 | 0.44235500 |
| 112 | PRKCH | 0.44213646 |
| 113 | RPS6KA6 | 0.43051606 |
| 114 | AKT3 | 0.42479783 |
| 115 | CAMK1D | 0.39799793 |
| 116 | BCKDK | 0.39754446 |
| 117 | DAPK2 | 0.36768137 |
| 118 | TAOK2 | 0.35075338 |
| 119 | MAPKAPK2 | 0.34241625 |
| 120 | NEK6 | 0.33184217 |
| 121 | MAP2K6 | 0.33143223 |
| 122 | TIE1 | 0.32158653 |
| 123 | EGFR | 0.31893286 |
| 124 | CASK | 0.31660856 |
| 125 | MAPK12 | 0.31364928 |
| 126 | NUAK1 | 0.31198302 |
| 127 | PDK1 | 0.30663544 |
| 128 | CDK9 | 0.30603679 |
| 129 | ABL1 | 0.30451894 |
| 130 | PIK3CG | 0.30167907 |
| 131 | RPS6KL1 | 0.28897926 |
| 132 | RPS6KC1 | 0.28897926 |
| 133 | EPHB1 | 0.27923680 |
| 134 | CDK6 | 0.26963333 |
| 135 | MUSK | 0.26893546 |
| 136 | STK16 | 0.26080400 |
| 137 | SGK1 | 0.25914554 |
| 138 | RPS6KA2 | 0.25742857 |
| 139 | CAMK1 | 0.25617885 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.08089219 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.91523150 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.71417555 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.64129151 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.63831672 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.58005581 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.46538163 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.41971868 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.37416327 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.28600472 |
| 11 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.27668885 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.23443487 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.19683339 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.05053319 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.96404424 |
| 16 | Pertussis_Homo sapiens_hsa05133 | 1.89108793 |
| 17 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.86284678 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.79388833 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.77008116 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.76499828 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.76183017 |
| 22 | Asthma_Homo sapiens_hsa05310 | 1.67935802 |
| 23 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.67019560 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.65830255 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.65140279 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.62305672 |
| 27 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.58176548 |
| 28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.56537796 |
| 29 | Legionellosis_Homo sapiens_hsa05134 | 1.54843782 |
| 30 | Malaria_Homo sapiens_hsa05144 | 1.51396720 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.51243280 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.50566316 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.43178940 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.42801148 |
| 35 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.38584204 |
| 36 | Hepatitis B_Homo sapiens_hsa05161 | 1.26056614 |
| 37 | Viral myocarditis_Homo sapiens_hsa05416 | 1.22798953 |
| 38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.22022716 |
| 39 | Salmonella infection_Homo sapiens_hsa05132 | 1.21365375 |
| 40 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.18561489 |
| 41 | Shigellosis_Homo sapiens_hsa05131 | 1.18146058 |
| 42 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.16738628 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.16390921 |
| 44 | Apoptosis_Homo sapiens_hsa04210 | 1.14137356 |
| 45 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.05733786 |
| 46 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.97409952 |
| 47 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.90927754 |
| 48 | Platelet activation_Homo sapiens_hsa04611 | 0.90820866 |
| 49 | Other glycan degradation_Homo sapiens_hsa00511 | 0.90573699 |
| 50 | Phagosome_Homo sapiens_hsa04145 | 0.90180053 |
| 51 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.89465882 |
| 52 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.87329745 |
| 53 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.85729066 |
| 54 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.84543853 |
| 55 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.82941967 |
| 56 | Hepatitis C_Homo sapiens_hsa05160 | 0.80735883 |
| 57 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.80285103 |
| 58 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.78489472 |
| 59 | Colorectal cancer_Homo sapiens_hsa05210 | 0.78297914 |
| 60 | Lysosome_Homo sapiens_hsa04142 | 0.75622004 |
| 61 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.69260423 |
| 62 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.68611615 |
| 63 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.68472355 |
| 64 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.68393620 |
| 65 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.67505278 |
| 66 | Homologous recombination_Homo sapiens_hsa03440 | 0.65481316 |
| 67 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.63927762 |
| 68 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.63789568 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.62481098 |
| 70 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.62423642 |
| 71 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.60375753 |
| 72 | Spliceosome_Homo sapiens_hsa03040 | 0.57694227 |
| 73 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.56643816 |
| 74 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.53697860 |
| 75 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.49830761 |
| 76 | Basal transcription factors_Homo sapiens_hsa03022 | 0.49405839 |
| 77 | Retinol metabolism_Homo sapiens_hsa00830 | 0.48779384 |
| 78 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.46465892 |
| 79 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.46223723 |
| 80 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45002588 |
| 81 | Morphine addiction_Homo sapiens_hsa05032 | 0.44680094 |
| 82 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44655302 |
| 83 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.43914694 |
| 84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43781594 |
| 85 | RNA degradation_Homo sapiens_hsa03018 | 0.43188753 |
| 86 | HTLV-I infection_Homo sapiens_hsa05166 | 0.42468430 |
| 87 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42200903 |
| 88 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.41658080 |
| 89 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.41628663 |
| 90 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.41201356 |
| 91 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.39841704 |
| 92 | Taste transduction_Homo sapiens_hsa04742 | 0.39644347 |
| 93 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38447463 |
| 94 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.38287809 |
| 95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37287106 |
| 96 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.36802892 |
| 97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.35459199 |
| 98 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.34018931 |
| 99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.33567472 |
| 100 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.33142096 |
| 101 | Peroxisome_Homo sapiens_hsa04146 | 0.33116099 |
| 102 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.32908953 |
| 103 | Amoebiasis_Homo sapiens_hsa05146 | 0.32860845 |
| 104 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32473914 |
| 105 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.32377170 |
| 106 | RNA polymerase_Homo sapiens_hsa03020 | 0.30004751 |
| 107 | Insulin resistance_Homo sapiens_hsa04931 | 0.29646297 |
| 108 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.29443655 |
| 109 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.29308499 |
| 110 | RNA transport_Homo sapiens_hsa03013 | 0.29279915 |
| 111 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28573764 |
| 112 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.28455011 |
| 113 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.28426279 |
| 114 | Nicotine addiction_Homo sapiens_hsa05033 | 0.28275309 |
| 115 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.27442990 |
| 116 | Lysine degradation_Homo sapiens_hsa00310 | 0.27314700 |
| 117 | Prostate cancer_Homo sapiens_hsa05215 | 0.27257700 |
| 118 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.26101088 |
| 119 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.25790517 |
| 120 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.25682379 |
| 121 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.24819243 |
| 122 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.24340669 |
| 123 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.23434661 |
| 124 | ABC transporters_Homo sapiens_hsa02010 | 0.23277649 |
| 125 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.23229770 |
| 126 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.22985319 |
| 127 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.22638126 |
| 128 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.22596657 |
| 129 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.21132198 |

